17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis.

      The Annals of Otology, Rhinology, and Laryngology
      Adult, Aged, Blood Loss, Surgical, statistics & numerical data, Blood Transfusion, adverse effects, Carcinoma, Squamous Cell, blood, pathology, surgery, Female, Head and Neck Neoplasms, Hematocrit, Hospitals, Humans, Logistic Models, Male, Meta-Analysis as Topic, Middle Aged, Missouri, Neoplasm Recurrence, Local, epidemiology, etiology, Neoplasm Staging, Odds Ratio, Registries, Retrospective Studies, Risk Factors, Serum Albumin, analysis

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To study the effect of transfusion on recurrence of squamous cell carcinoma of the head and neck, we analyzed the records of 143 patients with stage II through IV squamous cell carcinoma of the supraglottic larynx or hypopharynx for whom follow-up to recurrence or 5 years after surgical therapy was available. Variables studied were age, gender, TNM staging, duration of operation, estimated blood loss, units of blood products transfused, surgical margins, number of pathologic nodes, radiotherapy, chemotherapy, hematocrit, and serum albumin. Multivariate logistic regression demonstrated that transfusion, number of pathologic nodes, and preoperative hematocrit were significantly related to recurrence. The univariate odds ratio for tumor recurrence in patients receiving any blood products was 3.2 (95% confidence interval 1.5 to 6.9; p = .004). Based on a meta-analysis of the data from this study and the five published studies, the combined odds ratio for recurrence after transfusion was 2.6 (95% confidence interval 1.9 to 3.7; p less than .0001). These data identify a clinically important adverse effect of transfusion of blood products on tumor recurrence in patients with advanced head and neck cancer. We recommend a policy of blood conservation surgery to enhance cancer control, and we encourage further research to clarify the mechanism(s) of this effect.

          Related collections

          Author and article information

          Comments

          Comment on this article